Antiretroviral Therapy News

• Vitamins, OTC Drugs May Interact With HIV Antiretroviral Therapy OTC medications, food supplements, and other drugs may interact with antiretroviral therapy and harm people living with HIV, researchers in Denmark report.
  Medscape Medical News, May 20, 2022
• Support for Gilead Drug's Benefit Against Multidrug-Resistant HIV Lenacapavir produces higher levels of viral suppression after 26 weeks among patients with multidrug-resistant disease when given in addition to other antiretrovirals, according to results from the CAPELLA trial.
  Reuters Health Information, May 11, 2022
• ATS 2022 ATS 2022: Restoration in the Aftermath of COVID-19 Lessons learned from the pandemic will be a central theme of this year's meeting, held live for the first time since 2019.
  Medscape Medical News, May 10, 2022
• Decentralizing PrEP Offers a Roadmap for Retention University of Washington researchers tested a de-medicalized PrEP model at a sexual health clinic to increase PrEP initiation and retention.
  Medscape Medical News, May 10, 2022
• Can Individualized Care for Kidney Disease in HIV Improve Outcomes? A need for dose adjustments and the possibility of drug-drug interactions have been identified in a study of advanced kidney disease in persons living with HIV.
  Medscape Medical News, May 09, 2022
• New HIV Care Guidelines From the European AIDS Clinical Society The revised 2021 European AIDS Clinical Society (EACS) Guidelines contain extensive updates, guidance on COVID-19 management, and offer a broader range of preferred choices than US guidelines.
  Medscape Medical News, May 05, 2022
• Adequately PrEPping the Next Generation Despite advances in HIV prevention, adolescents and young adults are still sorely unprepared.
  Medscape Medical News, May 05, 2022
• Why Is Preexposure Prophylaxis So Underused in Brazil? Stigma and prejudice are implicated in the insufficient use of PrEP, but knowledge and availability of HIV prevention measures also may play a role.
  Medscape Medical News, April 27, 2022
• Polypharmacy Common Among Patients Aged 65 or Older With HIV The risk of polypharmacy increases as patients age and develop more comorbidities, which raises concerns about medications that are potentially inappropriate for patients with HIV.
  Medscape Medical News, April 25, 2022
• Well-Controlled HIV Does Not Impair mRNA Vaccine Response People living with well-controlled HIV infections are likely to have immune responses to the mRNA COVID-19 vaccines from Moderna and from Pfizer/BioNTech similar to those of otherwise healthy individuals, according to new data.
  Reuters Health Information, April 12, 2022
• Counterfeit HIV Drugs: Justice Department Opens Investigation A sophisticated criminal enterprise has been operating at scale to distribute and profit from counterfeit HIV drugs. The details read like a best-selling crime novel.
  Medscape Medical News, April 11, 2022
• HIV PrEP: Biden Admin Allocates $9.8B for National Program Can the US reach its goal to end the HIV/AIDS epidemic? The Biden Administration is putting a lot of $$ behind the effort.
  Medscape Medical News, April 01, 2022
• HIV Protease Inhibitors May Curb COVID-19 Risk Certain drugs used to treat HIV may have a role in preventing SARS-CoV-2 infections, according to preliminary data that may help explain why people living with the condition have not appeared to be at higher risk for serious COVID-19 despite being generally more vulnerable to infections.
  Reuters Health Information, March 29, 2022
• More Questions Than Answers When Managing HIV and Menopause Studies looking at HIV and menopause are few and far between, and some reach conflicting findings.
  Medscape Medical News, March 22, 2022
• ART Associated With Less Risk of Preterm Birth in Large US Study A large US study addresses a long-standing question raised by studies in resource-poor settings about birth outcomes of women with HIV receiving antiretroviral therapy (ART).
  Medscape Medical News, March 18, 2022
• PrEP Kidney Function Monitoring to Be Fine-Tuned The risk of kidney-related adverse events among patients receiving tenofovir disoproxil fumarate-based oral HIV pre-exposure prophylaxis is small, a systematic review and meta-analysis revealed.
  Reuters Health Information, March 17, 2022
• HIV Preventive Care Is Supposed to Be Free in the US The rules were issued clarifying that health plans need to cover the costs of prescription drugs to prevent HIV infection, lab tests, and medical appointments, at no cost. The erroneous billing continues.
  Kaiser Health News, March 03, 2022
• Protease Inhibitor Promising Against SARS-CoV-2 in Midstage Trial An experimental oral drug being developed by Redhill Biopharma interrupts a process that helps the coronavirus infect cells and might keep COVID-19 patients from becoming seriously ill, the company said.
  Reuters Health Information, March 02, 2022
• CROI 2022 Third Transplant Patient Cured of HIV Marks Important Firsts A third person who has been 'cured' of HIV through a unique transplant of stem cells has given hope for a larger-scale way to beat back the HIV epidemic that has plagued the world for four decades.
  WebMD Health News, February 16, 2022
• CROI 2022 16 Toddlers With HIV at Birth Had No Detectable Virus Since the Mississippi baby captured the imagination of scientists, researchers have been looking for a way to replicate that treatment-free remission. Should preemptive HIV ART apply to infants too?
  Medscape Medical News, February 16, 2022
• CAB-LA Cost Might Be a Deal-Breaker for Payers and Patients Patients and providers anxiously await distribution of long-acting injectable PrEP, but the ante might be too high.
  Medscape Medical News, February 02, 2022